Showing 4781-4790 of 19421 results for "".
The Power of Patient Advocacy in Daily Clinical Practice
https://reachmd.com/programs/project-oncology/the-power-of-patient-advocacy-in-daily-clinical-practice/24501/How can we incorporate patient advocacy into daily practice? Tune in.Overcoming the Challenges of Atopic Dermatitis Treatment
https://reachmd.com/programs/clinicians-roundtable/overcoming-the-challenges-of-atopic-dermatitis-treatment/27069/Learn how innovative treatments and lifestyle modifications can help treat atopic dermatitis.Considerations for the Use of Biologics in Children with Atopic Dermatitis
https://reachmd.com/series/dermatology-hub-neuroimmune-network/derm-hub/37152/Dawn Zhang Eichenfield, MD, PhD, a dermatologist at Rady Children's Hospital-San Diego and an assistant clinical professor of dermatology at the University of California, San Diego, School of Medicine, explains the most important factors to understand when prescribing biologics for pediatric atopicDevelopments in Schizophrenia Care: An Alternative to Dopamine Receptor Blockage
https://reachmd.com/programs/neurofrontiers/developments-in-schizophrenia-care-an-alternative-to-dopamine-receptor-blockage/32313/KarXT is a novel schizophrenia therapy that treats psychosis by stimulating muscarinic receptors. Hear about its development and potential impacts.Face Value with Modern Aesthetics: A Peptide-Powered Booster
https://reachmd.com/series/face-value/face-value-with-modern-aesthetics-a-peptide-powered-booster/37879/Face Value with Modern Aesthetics is a new video series in which we connect with leading experts in aesthetic medicine to discuss the latest innovations, insights, and trends shaping the industry. In this week's episode, Tess Mauricio, MD, FAAD, discusses a new peptide-powered booster and how she utCracking the Migraine Code: How AI May Transform Diagnosis and Treatment
https://reachmd.com/programs/frontlines-migraine/migraine-ai-diagnosis-treatment/48938/Migraine is a highly prevalent and complex neurologic disorder, but many patients face delays in diagnosis, limited access to specialists, and suboptimal treatment pathways. However, emerging artificial intelligence (AI) tools offer new opportunities to improve access to care and personalize therapyAssessing Atirmociclib Plus Letrozole in HR+/HER2- Metastatic Breast Cancer
https://reachmd.com/programs/project-oncology/assessing-atirmociclib-plus-letrozole-in-hrher2-metastatic-breast-cancer/36160/A study presented at the 2025 ESMO Congress evaluated the safety and efficacy of first-line atirmociclib combined with letrozole for patients with HR+/HER2- metastatic breast cancer. This Phase 1 trial focused on treatment-naive patients and explored whether selective CDK4 inhibition with continuousScreening for Cervical Cancer
https://reachmd.com/programs/cme/Screening-for-Cervical-Cancer/39290/Multidisciplinary experts explore biomarker-driven strategies, immunotherapy, and personalized care in cervical and endometrial cancer management.Background of Alzheimer's Disease
https://reachmd.com/programs/clinicians-roundtable/background-of-alzheimers-disease/117/Dr. Thies discusses the background of Alzheimer's Disease including factors associated with the disease and signs and symptoms.Proactive Pregnancy Planning and Reproductive Care in MS
https://reachmd.com/programs/neurofrontiers/pregnancy-planning-reproductive-care-ms/54249/Multiple sclerosis (MS) is often diagnosed during peak reproductive years, making proactive, informed care essential across the lifespan. Hear from Dr. Riley Bove as she discusses the importance of early, ongoing conversations about fertility, pregnancy, and menopause in this population. Dr.